The SHARE study is recruiting new study participants. SHARE is part of the longest-running and largest HIV research study in the U.S. This is a unique opportunity to contribute to the knowledge of HIV disease and HIV therapy over a lifetime. SHARE is NOT a treatment study and does NOT involve taking experimental medicines. You will continue to receive your medical care from your own medical care provider.
For more information, see the SHARE recruitment flyer.
The SNAP Project is a research study exploring sexual health promotion strategies among African-American/Black men. Eligible participants will be paid.
For more information on eligibility and how to get involved, see the SNAP study recruitment flyer.
The REPRIEVE study is recruiting new participants to study heart disease prevention in people with HIV. This is a clinical trial to see whether Pitavastatin can prevent heart disease and heart disease related deaths in people with HIV infection who are taking HIV medications.
For more information, see the REPRIEVE recruitment flyer.
This ACTG study is recruiting new participants for a 5-year study of the impact of Hepatitis C treatment. No new medicines are provided by the study. Eligible participants will be paid.
For more information, see the ACTG Hepatitis C study flyer.
This study is recruiting new participants with both HIV and Hepatitis C. Treatment, lab work, and biopsies will be provided by the study. Participants will be paid for participation in the biopsy substudy.
For more information, see the HIV/Hepatitis C study flyer.
This study is recruiting HIV-negative transgender adults. Participants will be paid.
For more information, see the recruitment flyer.